Tandem Diabetes Care
TNDM
261 hedge funds and large institutions have $3.03B invested in Tandem Diabetes Care in 2019 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 92 increasing their positions, 87 reducing their positions, and 51 closing their positions.
82% more call options, than puts
Call options by funds: $95.8M | Put options by funds: $52.6M
6% more repeat investments, than reductions
Existing positions increased: 92 | Existing positions reduced: 87
2% more first-time investments, than exits
New positions opened: 52 | Existing positions closed: 51
2% more capital invested
Capital invested by funds: $2.98B → $3.03B (+$58.1M)
0.21% less ownership
Funds ownership: 81.19% → 80.97% (-0.21%)
2% less funds holding
Funds holding: 265 → 261 (-4)
33% less funds holding in top 10
Funds holding in top 10: 12 → 8 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$28.6M |
| 2 |
Norges Bank
Oslo,
Norway
|
+$26.6M |
| 3 |
VOYA Investment Management
Atlanta,
Georgia
|
+$26.3M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$20.4M |
| 5 |
PC
Polar Capital
London,
United Kingdom
|
+$20.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$51.9M |
| 2 |
Two Sigma Advisers
New York
|
-$38.5M |
| 3 |
D.E. Shaw & Co
New York
|
-$33.5M |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$30.5M |
| 5 |
FAM
Fred Alger Management
New York
|
-$30M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BAM
301
Bruderman Asset Management
Locust Valley,
New York
| – | -$13K | -200 | Closed |
|
|
WAM
302
Wealthspire Advisors (Maryland)
Potomac,
Maryland
| – | -$6K | -100 | Closed |
|
|
CFA
303
Camarda Financial Advisors
Fleming Island,
Florida
| – | -$6K | -98 | Closed |
|
|
CHP
304
Cable Hill Partners
Portland,
Oregon
| – | -$5K | -81 | Closed |
|
|
MNBTD
305
Moody National Bank Trust Division
Galveston,
Texas
| – | -$5K | -80 | Closed |
|
306
Simplex Trading
Chicago,
Illinois
| – | -$5.16K | -80 | Closed |
|
307
Walleye Capital
New York
| – | -$3.87K | -60 | Closed |
|
|
CIAS
308
Capital Investment Advisory Services
Raleigh,
North Carolina
| – | -$3K | -45 | Closed |
|
309
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
| – | -$2K | -27 | Closed |
|
|
GWS
310
Glassman Wealth Services
Vienna,
Virginia
| – | +$194 | +3 | New |
|
TNDM Hedge Fund Activity: Q2 2019 in Review
261 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q2 2019, worth a combined $3.03B — up 2% from $2.98B a quarter earlier.
Buyers outnumbered sellers: 52 funds opened new TNDM positions and 51 closed out — a net gain of 1 holder — while 92 added to existing stakes and 87 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $28.6M. The largest seller was Two Sigma Investments, cutting an estimated $51.9M.
- 261 institutional investors held Tandem Diabetes Care (TNDM) as of Q2 2019, down from 265 in Q1 2019.
- Funds reported $3.03B of Tandem Diabetes Care stock for Q2 2019, up 2% quarter-over-quarter.
- 52 funds opened new Tandem Diabetes Care positions in Q2 2019 and 51 closed out, a net change of +1 holder.
- The largest Tandem Diabetes Care buyer in Q2 2019 was Wellington Management Group, an estimated $28.6M added.
- The largest Tandem Diabetes Care seller in Q2 2019 was Two Sigma Investments, an estimated $51.9M sold.
Based on aggregated 13F filings for Q2 2019.